Key facts
- Agloe Medical’s last known valuation is $5.2M (Oct 2021).
- It has raised $17.1M; the latest was Early Stage VC in Nov 2025.
- Notable investors include Qiming Venture Partners, Beijing State-owned Capital Operation and Management, Shun Xi Fund, Chang Development, CBC Group (Singapore) — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Agloe Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Agloe Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Agloe Medical
Developer and producer of class II and III medical devices designed to advance precision surgery through intelligent automation in healthcare. The company offers research and development of intelligent robots, software development, software outsourcing services, artificial intelligence software development, Class II and Class III medical devices, instruments and meters, electronic components and electromechanical components and equipment, retail of computer software, hardware, and auxiliary equipment, industrial control computers and systems, and metal products, thereby reducing surgeon workload, and improving patient outcomes.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Website
- agloemedical.com/
- Ownership
- Privately Held (backing)
Agloe Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Agloe Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Agloe Medical in its N-PORT filings yet. We sweep new filings monthly.